You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

Details for New Drug Application (NDA): 213438


✉ Email this page to a colleague

« Back to Dashboard


NDA 213438 describes HYDROXYUREA, which is a drug marketed by Barr, Barr Labs Inc, Endo Operations, Leading, Qilu, and Roxane, and is included in seven NDAs. It is available from twelve suppliers. Additional details are available on the HYDROXYUREA profile page.

The generic ingredient in HYDROXYUREA is hydroxyurea. There are ten drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the hydroxyurea profile page.
Summary for 213438
Tradename:HYDROXYUREA
Applicant:Leading
Ingredient:hydroxyurea
Patents:0
Pharmacology for NDA: 213438
Suppliers and Packaging for NDA: 213438
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HYDROXYUREA hydroxyurea CAPSULE;ORAL 213438 ANDA Marlex Pharmaceuticals, Inc. 10135-702 10135-702-01 100 CAPSULE in 1 BOTTLE, PLASTIC (10135-702-01)
HYDROXYUREA hydroxyurea CAPSULE;ORAL 213438 ANDA Golden State Medical Supply, Inc. 51407-909 51407-909-01 100 CAPSULE in 1 BOTTLE, PLASTIC (51407-909-01)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength500MG
Approval Date:Apr 8, 2020TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.